Cargando…
Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders
Interleukin-38 (IL-38) is the most recent member of the IL-1 family that acts as a natural inflammatory inhibitor by binding to cognate receptors, particularly the IL-36 receptor. In vitro, animal and human studies on autoimmune, metabolic, cardiovascular and allergic diseases, as well sepsis and re...
Autores principales: | Haghshenas, Mohammad Reza, Zamir, Mina Roshan, Sadeghi, Mahboubeh, Fattahi, Mohammad Javad, Mirshekari, Kimia, Ghaderi, Abbas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Libbey Eurotext
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134710/ https://www.ncbi.nlm.nih.gov/pubmed/37052152 http://dx.doi.org/10.1684/ecn.2022.0480 |
Ejemplares similares
-
Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis
por: Zareinejad, Mohammadrasul, et al.
Publicado: (2023) -
p53 codon 72 polymorphism association with head and neck squamous cell carcinoma
por: Mojtahedi, Zahra, et al.
Publicado: (2015) -
Investigation of TNF-α and IL-6 Levels in the Sera of Non-Melanoma Skin Cancer Patients
por: Ghahartars, Mehdi, et al.
Publicado: (2021) -
Simultaneous Increase in Serum Levels of IL-37 and IL-18 Binding Protein In Low-Grade and High-Grade Brain Tumors
por: Haghshenas, Mohammad Reza, et al.
Publicado: (2022) -
Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer
por: Ghahartars, Mehdi, et al.
Publicado: (2021)